• Biotalys announces Chief Financial Officer succession plan

    Tuesday March 14th 2023

  • New protein function could explain cause of neurological disease

    Tuesday March 14th 2023

  • UCB’s Board of Directors appoints Jonathan Peacock as new Chair

    Thursday March 9th 2023

  • Cancer Research UK signs multi-project collaboration with UCB to advance oncology antibody candidates

    Thursday March 9th 2023

  • Mithra announces promising topline safety results from Donesta® Phase 3 Study in North America

    Monday March 6th 2023

  • VIB spin-off Flamingo Therapeutics merges with Dynacure to create leading RNA therapeutics company in oncology

    Thursday March 2nd 2023

  • Confo Therapeutics announces Global Licensing Agreement with Lilly for peripheral pain candidate, CFTX-1554

    Thursday March 2nd 2023

  • Biocartis announces the US FDA 510(k) clearance for the Idylla™ MSI Test

    Thursday March 2nd 2023

  • Your news here?

  • CMT Research Foundation (USA) collaborates with Augustine Therapeutics on new therapy against Charcot-Marie-Tooth disease

    Thursday March 2nd 2023

  • Mithra announces compelling initial preclinical data in its research collaboration on novel tyrosine kinase inhibitors with BCI Pharma

    Thursday March 2nd 2023

  • Oxurion announces subscription agreement with Atlas providing the company with up to €20 million in funding

    Thursday March 2nd 2023


Strategic Partners